Every Form 4 that Broadway Financial Corp/Del (BYFC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow BYFC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BYFC filings page.
Carew Tina reported acquisition or exercise transactions in this Form 4 filing.
Tina Carew, EVP, CLO & Corporate Secretary of Broadway Financial, reported a grant of 4,921 shares of restricted common stock on July 28, 2026 at $10.16 per share. The award vests over four years under the Amended and Restated 2018 Long-Term Incentive Plan, and she now directly holds 4,921 shares. This amendment updates the grant date due to a clerical error.
Carew Tina reported acquisition or exercise transactions in this Form 4 filing.
Broadway Financial Corp executive Tina Carew, EVP, CLO & Corporate Secretary, received a grant of 4,921 shares of common stock as restricted stock. The award is priced at $10.16 per share, was granted on March 2, 2026, and vests over four years under the Amended and Restated 2018 Long-Term Incentive Plan. After this grant, she holds 4,921 shares directly, and the transaction is reported as not made under a Rule 10b5-1 trading plan.
Broadway Financial Corp. director Wayne-Kent A. Bradshaw reported a series of open-market sales of the company’s Common Stock. On May 26, 2026, he sold a total of 8,600 shares at prices ranging from about $9.36 to $9.68 per share. After these transactions, he directly holds 33,359 shares of Broadway Financial common stock. A footnote notes that the share amounts reflect a reverse stock split effective October 31, 2023 and include 5,216 shares allocated under the company’s ESOP.
Broadway Financial Corp. director Wayne-Kent A. Bradshaw reported selling a total of 1,400 shares of common stock on May 22, 2026. The sales were executed in multiple open-market transactions at prices between $9.51 and $9.69 per share.
The filing shows only common stock transactions, with no derivative exercises. A footnote states that the reported share amounts reflect a reverse stock split effective October 31, 2023 and include 5,216 shares allocated under the company’s ESOP.
Broadway Financial Corp director John Driver sold shares in the company. He completed an open-market sale of 6,500 shares of Common Stock at a price of $9.361 per share. After this transaction, he directly holds 2,711 shares of Broadway Financial common stock.
Driver John reported acquisition or exercise transactions in this Form 4 filing.
Broadway Financial Corporation director John Driver received an award of 2,675 shares of common stock on March 2, 2026. The unrestricted stock was issued under the company’s amended and restated 2018 Long Term Incentive Plan at a reported price of $7.85 per share, bringing his direct holdings to 9,211 shares.
Donovan Mary Ann reported acquisition or exercise transactions in this Form 4 filing.
Broadway Financial Corp director Mary Ann Donovan reported an equity award of common stock. She received 2,675 shares on March 2, 2026 at a reference price of $7.85 per share, issued as unrestricted stock under the Amended and Restated 2018 Long Term Incentive Plan. Following this grant, her direct holdings increased to 10,223 common shares, reflecting amounts already adjusted for a reverse stock split effective October 31, 2023.
Broadway Financial Corporation reported that EVP and Chief Credit Officer LaShanya Demetrice Washington acquired 6,480 shares of common stock as a restricted stock grant on March 2, 2026, at $7.85 per share. The award vests over four years under the company’s 2018 Long-Term Incentive Plan, bringing her direct holdings to 22,300 shares.
JOHNS MARIE C reported acquisition or exercise transactions in this Form 4 filing.
Broadway Financial Corporation director Marie C. Johns received an equity award of 2,675 shares of Common Stock on March 2, 2026. The award was granted at a price of $7.85 per share under the company’s amended and Restated 2018 Long Term Incentive Plan. Following this grant, Johns directly owns 10,223 shares of Broadway Financial common stock. A footnote explains that prior amounts were adjusted to reflect a reverse stock split effective October 31, 2023.
McGrady David J. reported acquisition or exercise transactions in this Form 4 filing.
Broadway Financial Corp. director David J. McGrady reported receiving an award of 2,675 shares of common stock on March 2, 2026. The unrestricted stock was granted under the company’s amended and Restated 2018 Long Term Incentive Plan, bringing his directly held stake to 10,223 shares.
Argrett Brian E reported acquisition or exercise transactions in this Form 4 filing.
Broadway Financial Corp. reported that President and CEO Brian E. Argrett was granted 23,793 shares of restricted common stock on March 2, 2026 at a reference price of $7.85 per share. Following this equity award, his directly held common stock position increased to 125,752 shares.
The restricted stock will vest over time, with 33% of the shares vesting on the first anniversary of the grant date and the remaining balance vesting ratably over the next 24 months. The filing also notes that the share amounts have been adjusted to reflect a reverse stock split effective October 31, 2023.
Bradshaw Wayne-Kent A. reported acquisition or exercise transactions in this Form 4 filing.
Broadway Financial Corp. director Wayne-Kent A. Bradshaw received an award of 2,675 shares of common stock on March 2, 2026. The shares were issued as unrestricted stock under the company’s Amended and Restated 2018 Long Term Incentive Plan.
After this grant, Bradshaw directly owns a total of 43,359 common shares, which includes 5,216 shares allocated under the ESOP and reflects adjustments for a reverse stock split effective October 31, 2023.
Broadway Financial Corporation executive William Justin Jennings reported an equity grant. He acquired 4,458 shares of common stock on March 2, 2026 as a grant or award valued at $7.85 per share. These are restricted shares that vest over four years under the company’s Amended and Restated 2018 Long-Term Incentive Plan. After this grant, he directly holds 9,394 common shares.
Hentges Mary reported acquisition or exercise transactions in this Form 4 filing.
Broadway Financial Corporation director Mary Hentges reported receiving a grant of 2,675 shares of common stock on March 2, 2026. The unrestricted shares were awarded at $7.85 per share under the company’s Amended and Restated 2018 Long Term Incentive Plan and are held directly.
Allen John Anthony reported acquisition or exercise transactions in this Form 4 filing.
Broadway Financial Corp. EVP and Chief Banking Officer John Anthony Allen received a grant of 7,833 shares of restricted common stock on March 2, 2026. The award was priced at $7.85 per share and increased his directly held common stock to 16,016 shares.
The restricted stock vests over four years under the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan, effective April 16, 2023. This represents equity-based compensation rather than an open-market purchase.
DAVIDSON ROBERT C JR reported acquisition or exercise transactions in this Form 4 filing.
Broadway Financial Corporation director Robert C. Davidson Jr. received an award of 2,675 shares of common stock on March 2, 2026 under the company’s Amended and Restated 2018 Long Term Incentive Plan. The shares were valued at $7.85 per share, bringing his direct holdings to 11,127 shares after the grant.
Ibrahim Zack reported acquisition or exercise transactions in this Form 4 filing.
Broadway Financial Corporation executive vice president and chief financial officer Zack Ibrahim reported receiving a grant of 11,521 shares of common stock on March 2, 2026. The restricted stock was granted at $7.85 per share and vests over four years, bringing his direct holdings to 51,267 shares.
Ross Dutch C. III reported acquisition or exercise transactions in this Form 4 filing.
Broadway Financial Corporation director reports stock award
Director Dutch C. Ross III received an award of 2,675 shares of Broadway Financial Corporation common stock on March 2, 2026, valued at $7.85 per share. The award consists of unrestricted stock granted under the company’s Amended and Restated 2018 Long Term Incentive Plan.
Following this grant, Ross directly holds a total of 14,062 shares of Broadway Financial common stock. The share amounts reflect adjustments related to a reverse stock split that was effective on October 31, 2023.
Broadway Financial Corp (BYFC) director reports stock sales. A single reporting person, serving as a director, sold a total of 10,000 shares of BYFC common stock through their broker between 10/02/2025 and 10/15/2025. The trades were executed in ten separate 1,000-share transactions at prices ranging from $7.0987 to $7.7 per share, described as part of ordinary course portfolio rebalancing. After these sales, the director beneficially owns 8,452 BYFC shares directly.
Broadway Financial (BYFC) reported an insider equity grant on Form 4. The company’s EVP, Chief Deposit Officer acquired 4,936 shares of common stock as restricted stock on 10/14/2025 at a reported price of $7.09. Following the transaction, the officer beneficially owned 4,936 shares, held directly.
The filing notes the award is a restricted stock grant with a 4-year vesting schedule under the Broadway Financial Corporation Amended and Restored 2018 Long-Term Incentive Plan effective April 16, 2023.